| CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids MM Ibrahim, F Porreca, J Lai, PJ Albrecht, FL Rice, A Khodorova, G Davar, ... Proceedings of the National Academy of Sciences 102 (8), 3093-3098, 2005 | 687 | 2005 |
| Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS MM Ibrahim, H Deng, A Zvonok, DA Cockayne, J Kwan, HP Mata, ... Proceedings of the National Academy of Sciences 100 (18), 10529-10533, 2003 | 618 | 2003 |
| CB2 cannabinoid receptor-mediated peripheral antinociception TP Malan Jr, MM Ibrahim, H Deng, Q Liu, HP Mata, T Vanderah, F Porreca, ... Pain 93 (3), 239-245, 2001 | 521 | 2001 |
| Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance TW Vanderah, LR Gardell, SE Burgess, M Ibrahim, A Dogrul, CM Zhong, ... Journal of Neuroscience 20 (18), 7074-7079, 2000 | 424 | 2000 |
| Regular exercise reverses sensory hypersensitivity in a rat neuropathic pain model: role of endogenous opioids NJ Stagg, HP Mata, MM Ibrahim, EJ Henriksen, F Porreca, TW Vanderah, ... Anesthesiology 114 (4), 940, 2011 | 381 | 2011 |
| Inhibition of inflammatory hyperalgesia by activation of peripheral CB2Cannabinoid receptors A Quartilho, HP Mata, MM Ibrahim, TW Vanderah, F Porreca, ... Anesthesiology 99 (4), 955-960, 2003 | 303 | 2003 |
| CB2 cannabinoid receptor agonists: pain relief without psychoactive effects? TP Malan Jr, MM Ibrahim, J Lai, TW Vanderah, A Makriyannis, F Porreca Current opinion in pharmacology 3 (1), 62-67, 2003 | 266 | 2003 |
| Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats TP Malan, MH Ossipov, LR Gardell, M Ibrahim, D Bian, J Lai, F Porreca Pain 86 (1-2), 185-194, 2000 | 238 | 2000 |
| CB2 cannabinoid receptor mediation of antinociception MM Ibrahim, ML Rude, NJ Stagg, HP Mata, J Lai, TW Vanderah, ... Pain 122 (1), 36-42, 2006 | 206 | 2006 |
| SARS-CoV-2 spike protein co-opts VEGF-A/neuropilin-1 receptor signaling to induce analgesia A Moutal, LF Martin, L Boinon, K Gomez, D Ran, Y Zhou, HJ Stratton, ... Pain 162 (1), 243-252, 2021 | 167 | 2021 |
| Formation of lipid reserves in fat body and eggs of the yellow fever mosquito, Aedes aegypti R Ziegler, MM Ibrahim Journal of insect physiology 47 (6), 623-627, 2001 | 156 | 2001 |
| Inhibition of pain responses by activation of CB2 cannabinoid receptors TP Malan Jr, MM Ibrahim, TW Vanderah, A Makriyannis, F Porreca Chemistry and physics of lipids 121 (1-2), 191-200, 2002 | 138 | 2002 |
| Long-lasting antinociceptive effects of green light in acute and chronic pain in rats MM Ibrahim, A Patwardhan, KB Gilbraith, A Moutal, X Yang, LA Chew, ... Pain 158 (2), 347-360, 2017 | 123 | 2017 |
| Cannabilactones: a novel class of CB2 selective agonists with peripheral analgesic activity AD Khanolkar, D Lu, M Ibrahim, RI Duclos, Jr, GA Thakur, TP Malan, Jr, ... Journal of medicinal chemistry 50 (26), 6493-6500, 2007 | 114 | 2007 |
| Loss of antiallodynic and antinociceptive spinal/supraspinal morphine synergy in nerve-injured rats: restoration by MK-801 or dynorphin antiserum D Bian, MH Ossipov, M Ibrahim, RB Raffa, RJ Tallarida, TP Malan Jr, J Lai, ... Brain research 831 (1-2), 55-63, 1999 | 104 | 1999 |
| Complications associated with stellate ganglion nerve block: a systematic review V Goel, AM Patwardhan, M Ibrahim, CL Howe, DM Schultz, H Shankar Regional Anesthesia & Pain Medicine 44 (6), 669-678, 2019 | 102 | 2019 |
| Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists SA Grenald, MA Young, Y Wang, MH Ossipov, MM Ibrahim, ... Neuropharmacology 116, 59-70, 2017 | 102 | 2017 |
| Mechanisms and pathways of pain photobiomodulation: a narrative review K Cheng, LF Martin, MJ Slepian, AM Patwardhan, MM Ibrahim The journal of pain 22 (7), 763-777, 2021 | 92 | 2021 |
| Constitutive activity at the cannabinoid CB1 receptor is required for behavioral response to noxious chemical stimulation of TRPV1: antinociceptive actions of CB1 inverse agonists B Fioravanti, M De Felice, CL Stucky, KA Medler, MC Luo, LR Gardell, ... Journal of Neuroscience 28 (45), 11593-11602, 2008 | 91 | 2008 |
| CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide A Moutal, X Yang, W Li, KB Gilbraith, S Luo, S Cai, L François-Moutal, ... Pain 158 (12), 2301-2319, 2017 | 86 | 2017 |
Frank PorrecaProfessor of Pharmacology, University of ArizonaOverená e-mailová adresa na: medadmin.arizona.edu
